
Varex Imaging Corporation VREX
$ 18.45
0.08%
Varex Imaging Corporation General and Administrative Expenses | VREX
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Varex Imaging Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 133 M | 138 M | 128 M | 118 M | 126 M | 142 M | 128 M | 126 M | 102 M | 85.8 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 142 M | 85.8 M | 123 M |
Quarterly General and Administrative Expenses Varex Imaging Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.9 M | 36 M | 32.7 M | 32.7 M | - | 32.9 M | 32.6 M | 33.8 M | - | 35.6 M | 35.5 M | 32.4 M | - | 32.1 M | 34.1 M | 30.3 M | - | 30.2 M | 25.3 M | 33.1 M | - | 29.2 M | 30.6 M | 34.8 M | 102 M | 31.4 M | 35.3 M | - | 92.3 M | 31.2 M | 30.3 M | 30.8 M | 94.3 M | 35.2 M | 30.8 M | 28.2 M | 73.3 M | 26.3 M | 28.2 M | 26.9 M | 63.5 M | 20.6 M | 26.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 102 M | 20.6 M | 38.5 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
6.89 B | $ 43.92 | 0.06 % | $ 65 B | ||
|
Cognyte Software Ltd.
CGNT
|
47.1 M | $ 8.52 | 0.06 % | $ 621 M | ||
|
ClearPoint Neuro
CLPT
|
16.5 M | $ 14.83 | 1.51 % | $ 420 M | ||
|
CONMED Corporation
CNMD
|
132 M | $ 45.38 | 0.44 % | $ 1.41 B | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 4.38 | 1.86 % | $ 273 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 15.6 | 0.75 % | $ 559 M | ||
|
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | ||
|
Medigus Ltd.
MDGS
|
9.96 M | - | 10.28 % | $ 55.5 M | ||
|
Electromed
ELMD
|
42.7 M | $ 27.88 | 0.07 % | $ 230 M | ||
|
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | ||
|
Establishment Labs Holdings
ESTA
|
165 M | $ 65.97 | 0.59 % | $ 1.95 B | ||
|
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 86.29 | 0.66 % | $ 50.5 B | ||
|
Nemaura Medical
NMRD
|
5.6 M | - | -17.8 % | $ 2.74 M | ||
|
Helius Medical Technologies
HSDT
|
23.1 M | $ 2.94 | 1.38 % | $ 64.8 M | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 5.64 | 1.26 % | $ 762 M | ||
|
Inogen
INGN
|
67.4 M | $ 5.36 | 2.49 % | $ 143 M | ||
|
InMode Ltd.
INMD
|
11.7 M | $ 14.26 | 0.49 % | $ 922 M | ||
|
Inspire Medical Systems
INSP
|
625 M | $ 70.5 | 2.46 % | $ 2.07 B | ||
|
IRIDEX Corporation
IRIX
|
7.73 M | $ 0.63 | 0.16 % | $ 10.7 M | ||
|
IRadimed Corporation
IRMD
|
17.8 M | $ 85.76 | 0.66 % | $ 1.09 B | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
AxoGen
AXGN
|
44.6 M | $ 43.39 | 0.16 % | $ 2 B | ||
|
Align Technology
ALGN
|
1.76 B | $ 146.78 | 0.79 % | $ 10.6 B | ||
|
LENSAR
LNSR
|
45.2 M | $ 6.92 | 0.28 % | $ 82.7 M | ||
|
Sientra
SIEN
|
41.5 M | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
145 M | - | - | $ 1.07 B | ||
|
Medtronic PLC
MDT
|
11.8 B | $ 88.64 | 0.98 % | $ 114 B | ||
|
MiMedx Group
MDXG
|
56.5 M | $ 4.67 | 0.1 % | $ 690 M | ||
|
Surgalign Holdings
SRGA
|
95.9 M | - | -32.98 % | $ 1.68 M | ||
|
ShockWave Medical
SWAV
|
95.3 M | - | - | $ 12.3 B | ||
|
Myomo
MYO
|
14 M | $ 1.61 | 0.6 % | $ 67.4 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
21.6 M | $ 0.64 | 0.02 % | $ 41.5 M | ||
|
InspireMD
NSPR
|
20.7 M | $ 0.7 | 0.71 % | $ 45 M | ||
|
Orthofix Medical
OFIX
|
554 M | $ 9.44 | 3.06 % | $ 374 M | ||
|
Outset Medical
OM
|
37.9 M | $ 3.05 | 1.29 % | $ 46.4 K | ||
|
Insulet Corporation
PODD
|
1.16 B | $ 136.13 | 0.26 % | $ 9.58 B | ||
|
Quanterix Corporation
QTRX
|
138 M | $ 3.27 | 2.83 % | $ 139 M | ||
|
Titan Medical
TMDI
|
12.4 M | - | -26.32 % | $ 19.6 M | ||
|
AVITA Medical
RCEL
|
27.4 M | $ 11.84 | 2.25 % | $ 330 M | ||
|
Natus Medical Incorporated
NTUS
|
52.8 M | - | 1.94 % | $ 1.05 B | ||
|
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | ||
|
Apyx Medical Corporation
APYX
|
15.8 M | $ 2.96 | 4.59 % | $ 122 M | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 1.88 | 0.53 % | $ 5.21 M | ||
|
Smith & Nephew plc
SNN
|
3.1 B | $ 26.91 | 0.86 % | $ 23.3 B | ||
|
Accuray Incorporated
ARAY
|
45.4 M | $ 0.22 | 1.84 % | $ 27 M | ||
|
Inari Medical
NARI
|
361 M | - | - | $ 4.23 B | ||
|
Sensus Healthcare
SRTS
|
7.87 M | $ 2.94 | 1.03 % | $ 48 M | ||
|
Bruker Corporation
BRKR
|
946 M | $ 64.18 | 0.28 % | $ 9.74 B | ||
|
Stryker Corporation
SYK
|
8.65 B | $ 272.36 | 0.97 % | $ 104 B |